Vik Chopra, an analyst from Wells Fargo, reiterated the Buy rating on Masimo (MASI – Research Report). The associated price target was lowered to $190.00.
Vik Chopra has given his Buy rating due to a combination of factors that suggest a positive outlook for Masimo. Despite the impact of tariffs, the company’s first-quarter performance exceeded expectations, with both revenue and earnings per share surpassing forecasts. Management remains confident in achieving long-term operating margin targets and has even raised these targets slightly, excluding the effects of tariffs.
Additionally, Masimo is actively working on strategies to mitigate the tariff impact, which is expected to affect costs throughout the year. The planned sale of Sound United to Harman is anticipated to close by the end of 2025, providing potential opportunities for share repurchases and other value-maximizing actions. These factors, along with a stable revenue outlook and strategic initiatives, underpin Chopra’s Buy rating for Masimo.
Chopra covers the Healthcare sector, focusing on stocks such as Align Tech, DENTSPLY SIRONA, and Henry Schein. According to TipRanks, Chopra has an average return of 1.6% and a 34.38% success rate on recommended stocks.